Galip Can Uyar: Can Wearables Predict Post-Discharge Risk in Metastatic Cancer?
Galip Can Uyar/LinkedIn

Galip Can Uyar: Can Wearables Predict Post-Discharge Risk in Metastatic Cancer?

Galip Can Uyar, Medical Doctor at Etlik City Hospital, shared on LinkedIn:

“Published!

Can wearables predict post-discharge risk in metastatic cancer?

Lower post-discharge mobility was associated with higher 90-day readmission and mortality.”

Title: Wearable-derived postdischarge mobility as a digital biomarker for 90-day readmission and mortality in metastatic cancer

Authors: Orhun Akdogan, Galip Can Uyar, Cristiane Decat Bergerot, Joseph W. McCollom, Tuba Ugur Tuzcu, Enes Yesilbas, Fatih Umunc, Kadriye Baskurt, Gozde Savas, Ozgen Ahmet Yildirim, Fatih Gurler, Kadriye Bir Yucel, Ugur Coskun, Aytug Uner, Ahmet Ozet, Ozan Yazici, Nuriye Ozdemir, Berna Oksuzoglu, Osman Sutcuoglu.

Read the Full Article.

Galip Can Uyar: Can Wearables Predict Post-Discharge Risk in Metastatic Cancer?

Other articles featuring Galip Can Uyar on OncoDaily.